MedTrace Logo

Assessment of Esophageal Epithelium Integrity With Use of a Novel Mucosal Impedance Device

NCT03103789 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2025-05-21

No results posted yet for this study

Summary

The objective of this study is to design and use a novel, minimally invasive mucosal impedance (MI) technology to inexpensively and accurately test mucosal health in suspected gastroesophageal reflux disease (GERD) and nonerosive reflux disease (NERD) patients as compared to those without GERD.

Conditions

  • Gastro Esophageal Reflux

Interventions

DIAGNOSTIC_TEST

single catheter mucosal impedance testing

DIAGNOSTIC_TEST

balloon assembly mucosal impedance testing

Sponsors & Collaborators

  • Sandhill Scientific

    collaborator INDUSTRY

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Michael Vaezi, MD, PhD · Vanderbilt University Medical Center

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-29
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03103789 on ClinicalTrials.gov